相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice
Wilma L. Suarez-Pinzon et al.
DIABETES (2008)
The cell-specific pattern of cholecystokinin peptides in endocrine cells Versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6
Jens F. Rehfeld et al.
ENDOCRINOLOGY (2008)
Incretin-based therapies in type 2 diabetes mellitus
Chee W. Chia et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
L. Blonde et al.
DIABETES OBESITY & METABOLISM (2006)
Cholecystokinin and gastrin receptors
Marlene Dufresne et al.
PHYSIOLOGICAL REVIEWS (2006)
Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice
WL Suarez-Pinzon et al.
DIABETES (2005)
The [pre-] history of the incretin concept
W Creutzfeldt
REGULATORY PEPTIDES (2005)
One week's treatment with the long-acting glucagon-like peptide 1 derivative liraglutide (NN2211) markedly improves 24-h glycemia and α- and β-cell function and reduces endogenous glucose release in patients with type 2 diabetes
KB Degn et al.
DIABETES (2004)
Altered control of gastric acid secretion in gastrin-cholecystokinin double mutant mice
D Chen et al.
GASTROENTEROLOGY (2004)
Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycaemia in C57Bl6/J mice treated with alloxan
I Rooman et al.
DIABETOLOGIA (2004)
Gastro-intestinal hormones GIP and GLP-1
TJ Kieffer
ANNALES D ENDOCRINOLOGIE (2004)
Peptide receptors as molecular targets for cancer diagnosis and therapy
JC Reubi
ENDOCRINE REVIEWS (2003)
Distribution of CCK1 and CCK2 receptors in normal and diseased human pancreatic tissue
JC Reubi et al.
GASTROENTEROLOGY (2003)
Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin
SJ Brand et al.
PHARMACOLOGY & TOXICOLOGY (2002)
Gastrin stimulates beta-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreas tissue
I Rooman et al.
DIABETES (2002)
Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa
F Schmitz et al.
REGULATORY PEPTIDES (2001)
The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33
JF Rehfeld et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
分享论文
